WT1 and Wilms tumor: The first evidence that a WT1 mutation could be leukemogenic was a report describing a Wilms tumor survivor with WAGR syndrome, who by definition harbored a germline heterozygous deletion of the WT1 gene, and later developed acute myeloid leukemia (AML) with a new somatic WT1 mutation in the remaining allele [8].